ILMN peer analysis
Illumina (ILMN) against its competitors: price, today's move, 1-year return and market value side by side.
ILMN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLLN BillionToOne | $113.32 | -1.32% | – | – |
| GH Guardant Health | $178.80 | -3.51% | 93.49% | $24.87B |
| MYGN Myriad Genetics | $6.35 | -4.80% | -20.13% | $637.98M |
| NEO NeoGenomics | $17.38 | -3.07% | 79.36% | $2.32B |
| NTRA Natera | $421.00 | 1.62% | 118.92% | $62.85B |
| PACB Pacific Biosciences | $2.66 | 2.11% | 37.11% | $901.41M |
| PSNL Personalis | $15.80 | -0.13% | 65.19% | $1.70B |
| SOPH SOPHiA GENETICS | $7.63 | -4.27% | 47.01% | – |
| TXG 10x Genomics | $71.25 | 1.63% | 472.75% | $10.63B |
| WGS GeneDx | $69.06 | -2.76% | -47.48% | $2.12B |
| ILMN Illumina | $235.99 | -18.64% | 138.35% | $43.80B |
- ILMN's peers: BLLN (BillionToOne), GH (Guardant Health), MYGN (Myriad Genetics), NEO (NeoGenomics), NTRA (Natera), PACB (Pacific Biosciences), PSNL (Personalis), SOPH (SOPHiA GENETICS).
Updated 2026-11-02 17:14 UTC